Amphastar Pharmaceuticals, Inc. (AMPH) vs Eton Pharmaceuticals, Inc. (ETON)
- Amphastar Pharmaceuticals, Inc. AMPH 25.87 −2.08%
- Eton Pharmaceuticals, Inc. ETON 50.40 −1.81%
Amphastar Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Eton Pharmaceuticals, Inc. is the larger, with a market value of $1.5B against $1.1B — 1.3× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 107×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 81.5% against 1.02%. Eton Pharmaceuticals, Inc. has the higher net margin (12.0% vs 10.8%) and the higher return on invested capital (21.4% vs 6.57%). Across the 21 metrics below, Amphastar Pharmaceuticals, Inc. leads on 11 and Eton Pharmaceuticals, Inc. on 10.
Valuation
Profitability
| Metric | AMPH | ETON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 47.68% | 57.87% | 53.94% |
| Operating margin | 15.66% | 15.44% | 0.00% |
| Net margin | 10.76% | 12.02% | 0.00% |
| Free cash flow margin | 20.94% | (7.94%) | 0.00% |
| Return on equity | 10.30% | 35.97% | (0.40%) |
| Return on assets | 4.68% | 11.67% | (3.32%) |
| Return on invested capital | 6.57% | 21.39% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack